Effects of Epeleuton, a Novel Synthetic Second‐Generation n‐3 Fatty Acid, on Non‐Alcoholic Fatty Liver Disease, Triglycerides, Glycemic Control, and Cardiometabolic and Inflammatory Markers

BACKGROUND: Epeleuton is 15‐hydroxy eicosapentaenoic acid ethyl ester, a second‐generation synthetic n‐3 fatty acid derivative of eicosapentaenoic acid. The primary objective was to assess the effect of epeleuton on markers of nonalcoholic fatty liver disease (NAFLD) with post hoc analyses of cardio...

Descripción completa

Detalles Bibliográficos
Autores principales: Climax, John, Newsome, Philip N., Hamza, Moayed, Weissbach, Markus, Coughlan, David, Sattar, Naveed, McGuire, Darren K., Bhatt, Deepak L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660824/
https://www.ncbi.nlm.nih.gov/pubmed/32779505
http://dx.doi.org/10.1161/JAHA.119.016334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660824/
https://www.ncbi.nlm.nih.gov/pubmed/32779505
http://dx.doi.org/10.1161/JAHA.119.016334

Ejemplares similares